A drop in December new home sales weighed the markets down during the midday with the Dow losing 27 points to 15,851. Nasdaq tumbled 48 points to 4079.
On the upside
Oramed Pharmaceuticals (Nasdaq: ORMP) will announce results from a Phase 2a clinical trial of its type 2 diabetes oral insulin treatment ORMD-0801 at the Tel Aviv Stock Exchange on January 30, 2014.
Sprint (NYSE: S) partnered with Pogoplug to offer unlimited cloud storage to its smartphone customers.
Rayonier (NYSE: RYN) reported higher fourth quarter earnings and announced plans to separate into two independent, publicly traded companies.
On the downside
A Plug Power (Nasdaq: PLUG) director sold shares of company stock last week.
Regis (NYSE: RGS) widened second quarter losses more than expected as revenue dropped.
Nam Tai Electronics (NYSE: NTE) reported sharply lower preliminary fourth quarter earnings and revenue.
In the broad market, declining issues outpaced advancers by a margin of more than 4 to 1 on both the NYSE and on Nasdaq. The broader S&P 500 fell 9 points to 1781. Bitcoin slipped $5.09 or 0.53% to $960.01.
